Bharat Biotech controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2021
Brazil suspends Covaxin contract amid allegations
Issue disclosure
Brazil's health ministry announced a temporary suspension of the Covaxin contract amid allegations of possible corruption and irregularities in the vaccine deal. Bharat Biotech denied wrongdoing related to vaccine supply.
Brazil’s health ministry announced a temporary suspension of the Covaxin contract amid allegations of possible corruption and irregularities in the vaccine deal. Bharat Biotech denied wrongdoing related to vaccine supply.
Company response
Denial — Bharat Biotech
Bharat Biotech has denied any allegation of wrongdoing with respect to vaccine supply.
Source excerpt
The Health Ministry official said he faced pressure to greenlight the import of Indian pharmaceutical Bharat Biotech's Covaxin vaccine and that there were irregularities in the invoices — particularly a $45 million upfront payment to a Singapore-based company.
Brazil health ministry on Tuesday announced that the government is “temporarily suspending” the Covaxin contract even as President Jair Bolsonaro is under fire for possible corruption in the vaccine deal